Ardent Health (NYSE:ARDT) Downgraded by Wall Street Zen to Hold

Ardent Health (NYSE:ARDT) was downgraded by research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a report released on Sunday.

ARDT has been the topic of several other reports. UBS Group upped their price objective on Ardent Health from $13.00 to $13.50 and gave the company a “buy” rating in a research note on Thursday, May 7th. Weiss Ratings restated a “sell (d+)” rating on shares of Ardent Health in a research report on Friday, June 12th. Royal Bank Of Canada decreased their price target on Ardent Health from $13.00 to $12.00 and set an “outperform” rating on the stock in a research note on Thursday. Finally, Zacks Research upgraded Ardent Health from a “strong sell” rating to a “hold” rating in a research report on Wednesday, March 25th. Seven investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, Ardent Health has an average rating of “Hold” and an average target price of $14.12.

Ardent Health Price Performance

Shares of Ardent Health stock traded up $0.01 during trading on Friday, hitting $10.10. 416,784 shares of the company’s stock traded hands, compared to its average volume of 532,930. The company has a market cap of $1.45 billion, a PE ratio of 10.63, a PEG ratio of 2.28 and a beta of 0.76. The firm’s fifty day moving average price is $9.60 and its 200 day moving average price is $9.25. Ardent Health has a twelve month low of $7.71 and a twelve month high of $15.48. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.12 and a quick ratio of 2.00.

Ardent Health (NYSE:ARDT) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.18 by $0.10. The firm had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.58 billion. Ardent Health had a net margin of 2.09% and a return on equity of 13.85%. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. Analysts forecast that Ardent Health will post 1.1 earnings per share for the current year.

Insiders Place Their Bets

In other news, CFO Alfred Lumsdaine acquired 10,000 shares of the company’s stock in a transaction dated Friday, June 5th. The stock was bought at an average price of $8.81 per share, with a total value of $88,100.00. Following the completion of the acquisition, the chief financial officer owned 329,183 shares in the company, valued at approximately $2,900,102.23. This represents a 3.13% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 1.90% of the company’s stock.

Institutional Trading of Ardent Health

Several large investors have recently made changes to their positions in the business. The Manufacturers Life Insurance Company increased its stake in shares of Ardent Health by 3.7% in the first quarter. The Manufacturers Life Insurance Company now owns 29,812 shares of the company’s stock valued at $255,000 after buying an additional 1,072 shares in the last quarter. Geode Capital Management LLC lifted its position in Ardent Health by 0.6% during the 2nd quarter. Geode Capital Management LLC now owns 286,848 shares of the company’s stock worth $3,918,000 after buying an additional 1,769 shares in the last quarter. Caitong International Asset Management Co. Ltd lifted its position in Ardent Health by 1,177.7% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company’s stock worth $25,000 after buying an additional 2,638 shares in the last quarter. Alliancebernstein L.P. grew its holdings in Ardent Health by 24.8% during the 3rd quarter. Alliancebernstein L.P. now owns 16,472 shares of the company’s stock worth $218,000 after acquiring an additional 3,272 shares during the last quarter. Finally, New York State Common Retirement Fund increased its position in Ardent Health by 121.4% in the 2nd quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock valued at $85,000 after acquiring an additional 3,400 shares in the last quarter.

About Ardent Health

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.